PER 0.00% 8.0¢ percheron therapeutics limited

Ann: ATL1102 Revised Plans accelerate reporting of unblinded data, page-78

  1. 13,168 Posts.
    lightbulb Created with Sketch. 1387
    https://themarketherald.com.au/antisense-therapeutics-asxanp-revises-trial-plan-for-muscular-dystrophy-treatment-2022-09-07/?utm_source=threadview%20tmh%20widget&utm_medium=widget&utm_campaign=threadview%20tmh%20widget%20%7C%20click&utm_content=https://hotcopper.com.au/threads/ann-atl1102-revised-plans-accelerate-reporting-of-unblinded-data.6945031/page-76?post_id=63571412&utm_term=ANP
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.